分析:全球发病率和死亡率的肝硬化在代谢功能障碍相关的脂肪性肝病
相关实验视频
Updated: Jun 4, 2025

08:58
Optimized Analysis of In Vivo and In Vitro Hepatic Steatosis
Published on: March 11, 2017
15.9K
Soroor Owrangi1, James M Paik1,2,3, Pegah Golabi1,2,3
1Beatty Liver and Obesity Research Program, Inova Health System, Falls Church, Virginia, USA.
Alimentary pharmacology & therapeutics
|December 19, 2024
概括
与代谢功能障碍相关的脂肪性肝病 (MASLD) 肝硬化是常见的,在全科医院影响全球3.26%,在高风险环境中影响14.51%. 这凸显了对MASLD患者更好的查和管理的需要.
科学领域:
- 肝病学 肝病学是一种肝病学.
- 胃肠病学 胃肠病学
- 公共卫生 公共卫生
背景情况:
- 与代谢功能障碍相关的脂肪性肝病 (MASLD) 是一个重大的全球健康挑战.
- 与MASLD相关的肝硬化病的确切患病率和死亡率尚未确定,这阻碍了有效的公共卫生干预.
研究的目的:
- 为了估计MASLD患者中肝硬化的全球患病率.
- 确定与MASLD相关的肝硬化相关的全球死亡率.
主要方法:
- 在主要数据库 (PubMed,MEDLINE,EMBASE,Web of Science,SCOPUS) 进行了系统的文献搜索,截至2024年6月.
- 研究被分为一般实践和高风险环境 (住院或转诊进行活检).
- 一个随机效应模型被用来进行分析,遵循PRISMA指南.
主要成果:
- 35项涉及513,742名患者的研究符合纳入标准.
- 在MASLD中,肝硬化的全球患病率为3.26% (一般实践) 和14.51% (高风险环境).
- 在高风险群体中,北美/澳大利亚 (18.38%) 与欧洲 (10.16%) 和亚洲 (9.12%) 的患病率较高. 基于ICD的诊断显示患病率 (27.43%) 比通过活检诊断 (13.24%) 高. 所有原因的死亡率为每100人年7.91.
结论:
- 与MASLD相关的肝硬化在全球有相当大的患病率,具有显著的区域和诊断差异.
- 调查结果表明,对于MASLD患者来说,急需加强查方案和管理策略.
- 改善公共卫生策略是必要的,以应对与MASLD相关的肝硬化病的负担.
关键词:
马什 (MASH) 是一个非常重要的产品.马斯尔德 马斯尔德是什么意思这是NAFLD.纳什·纳什 (Nash Nash) 是一个名为纳什的城市.先进的纤维化.肝硬化是肝硬化的一种疾病.死亡率 死亡率更多相关视频
07:12Author Spotlight: Analysis of Fluorescent-Stained Lipid Droplets with 3D Reconstruction for Hepatic Steatosis Assessment
Published on: June 2, 2023
6.2K
07:03Author Spotlight: Establishing MASLD Cell Models for Investigating Disease Mechanisms and the Lipid-Lowering Effects of Koumiss
Published on: July 19, 2024
779
相关概念视频
Diseases of the Liver and Gallbladder
450
Liver and gallbladder diseases are a significant health concern, with prominent conditions including cirrhosis, hepatitis, non-alcoholic fatty liver disease (NAFLD), and gallstones. Jaundice is a common manifestation of liver and biliary disease.
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not...
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not...
450
Overview of Lipid Metabolism
1.0K
Lipid metabolism is a crucial process in the human body that involves the synthesis and degradation of lipids. This process is essential for energy production, cell membrane formation, and hormone production, among other functions.
Lipolysis: The Breakdown of Lipids:
Lipolysis is the process of breaking down lipids, particularly triglycerides, into glycerol and fatty acids. This process typically occurs in the adipose tissue and is triggered by various hormones, including glucagon and...
Lipolysis: The Breakdown of Lipids:
Lipolysis is the process of breaking down lipids, particularly triglycerides, into glycerol and fatty acids. This process typically occurs in the adipose tissue and is triggered by various hormones, including glucagon and...
1.0K